Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 6, 2011, Pages 1054-1058

  Waser, Beatrice ^a   Reubi, Jean Claude ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Exendin; Exendin(9 39) antagonist; Glucagon like peptide 1 receptor; Pancreatic tissues; Peptide receptor tumour targeting; Species selectivity

Indexed keywords

BOLTON HUNTER EXENDIN[9-39] I 125; BOLTON HUNTER REAGENT I 125; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE IODINE I 125; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; INSULINOMA; ISOTOPE LABELING; MOUSE; NONHUMAN; PANCREAS; RECEPTOR AFFINITY;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULINOMA; ISOTOPE LABELING; MICE; PANCREAS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RECEPTORS, GLUCAGON;

EID: 79958071590     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-010-1701-0     Document Type: Article

References (10)

1. JJ Holst 2007 The physiology of glucagon-like peptide 1 Physiol Rev 87 1409 1439 17928588 10.1152/physrev.00034.2006 1:CAS:528:DC%2BD2sXhtlaqu7jI (Pubitemid 350041474)
2. JC Reubi B Waser 2003 Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting Eur J Nucl Med Mol Imaging 30 781 793 12707737 10.1007/s00259-003- 1184-3 1:CAS:528:DC%2BD3sXjsF2ksbs%3D (Pubitemid 36612963)
3. D Wild H Mäcke E Christ B Gloor JC Reubi 2008 Glucagon-like peptide 1-receptor scans to localize occult insulinomas N Engl J Med 359 766 768 18703486 10.1056/NEJMc0802045 1:CAS:528:DC%2BD1cXhtVSht73O
4. E Christ D Wild F Forrer M Brändle R Sahli T Clerici, et al. 2009 Glucagon-like peptide-1 receptor imaging for localization of insulinomas J Clin Endocrinol Metab 94 4398 4405 19820010 10.1210/jc.2009-1082 1:CAS:528: DC%2BD1MXhsVejtLfK
5. JC Reubi 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy Endocr Rev 24 389 427 12920149 10.1210/er.2002-0007 1:CAS:528:DC%2BD3sXntlKjtbs%3D (Pubitemid 37056239)
6. M Ginj H Zhang B Waser R Cescato D Wild X Wang, et al. 2006 Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors Proc Natl Acad Sci U S A 103 16436 16441 17056720 10.1073/pnas.0607761103 1:CAS:528:DC%2BD28Xht1WmsLjJ (Pubitemid 44715214)
7. R Cescato T Maina B Nock A Nikolopoulou D Charalambidis V Piccand, et al. 2008 Bombesin receptor antagonists may be preferable to agonists for tumor targeting J Nucl Med 49 318 326 18199616 10.2967/jnumed.107.045054 1:CAS:528:DC%2BD1cXivVOltb8%3D (Pubitemid 351225672)
8. E Mukai K Toyoda H Kimura H Kawashima H Fujimoto M Ueda, et al. 2009 GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging Biochem Biophys Res Commun 389 523 526 19737540 10.1016/j.bbrc.2009.09.014 1:CAS:528:DC%2BD1MXht1Gks7nE
9. A Wicki D Wild D Storch C Seemayer M Gotthardt M Behe, et al. 2007 [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma Clin Cancer Res 13 3696 3705 17575235 10.1158/1078-0432.CCR-06-2965 1:CAS:528: DC%2BD2sXmsFCqu70%3D (Pubitemid 46955134)
10. T Maina BA Nock H Zhang A Nikolopoulou B Waser JC Reubi, et al. 2005 Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs J Nucl Med 46 823 830 15872357 1:CAS:528:DC%2BD28XitFSqsb0%3D